Bayesian Spatial Binary Regression for Label Fusion in Structural Neuroimaging

TL;DR

This paper introduces a Bayesian spatial regression model for label fusion in neuroimaging that improves hippocampal segmentation accuracy and provides uncertainty measures, aiding early Alzheimer's detection.

Contribution

It presents a novel Bayesian approach to label fusion that incorporates covariate information and yields meaningful uncertainty estimates.

Findings

Incorporating tissue classification improves segmentation accuracy.

Bayesian model provides uncertainty measures for hippocampal volumes.

Method enhances early detection of Alzheimer's disease.

Abstract

Alzheimer's disease is a neurodegenerative condition that accelerates cognitive decline relative to normal aging. It is of critical scientific importance to gain a better understanding of early disease mechanisms in the brain to facilitate effective, targeted therapies. The volume of the hippocampus is often used in diagnosis and monitoring of the disease. Measuring this volume via neuroimaging is difficult since each hippocampus must either be manually identified or automatically delineated, a task referred to as segmentation. Automatic hippocampal segmentation often involves mapping a previously manually segmented image to a new brain image and propagating the labels to obtain an estimate of where each hippocampus is located in the new image. A more recent approach to this problem is to propagate labels from multiple manually segmented atlases and combine the results using a process known as label fusion. To date, most label fusion algorithms employ voting procedures with voting weights assigned directly or estimated via optimization. We propose using a fully Bayesian spatial regression model for label fusion that facilitates direct incorporation of covariate information while making accessible the entire posterior distribution. Our results suggest that incorporating tissue classification (e.g, gray matter) into the label fusion procedure can greatly improve segmentation when relatively homogeneous, healthy brains are used as atlases for diseased brains. The fully Bayesian approach also produces meaningful uncertainty measures about hippocampal volumes, information which can be leveraged to detect significant, scientifically meaningful differences between healthy and diseased populations, improving the potential for early detection and tracking of the disease.